Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
University of California San Francisco, San Francisco, California Children's Hospital Colorado, Aurora, Colorado Children's Hospital of Philadelphia, Philadelphia, Pennsylvania University of Pennsylvania, Philadelphia, Pennsylvania Age range
5 Years – 40 Years
Last updated November 2025